Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$20.59 +0.59 (+2.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Assets (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE's Assets came in at $1.1 billion for Q2 2026, up 88.4% from $582.32 million a year earlier and up 39.1% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Viridian Therapeutics, Inc.\DE's Assets was $899.42 million, up 21.1% from FY2024.

  • Assets has increased in each of the last six years, with a five-year compound annual growth rate of 46.9% (FY2020 to FY2025).
  • Going back by year, Assets was $742.4 million in FY2024 (+51.4%), $490.42 million in FY2023 (+12.7%), $435.09 million in FY2022 (+113.6%) and $203.71 million in FY2021 (+55.2%).
  • The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2013.
  • Year-over-year, Assets has increased for three consecutive quarters, with growth averaging 36.8% over the last eight quarters.
  • The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 573.7%), and the weakest in Q3 2023 (a decline of 25.4%).
  • Business Quant data shows VRDN's Assets at $789.02 million (Q1 2026), $899.42 million (Q4 2025) and $577.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn - 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Bn
Mar 31, 2026 789.02 Mn
Dec 31, 2025 899.42 Mn
Sep 30, 2025 577.14 Mn
Jun 30, 2025 582.32 Mn
Mar 31, 2025 660.98 Mn
Dec 31, 2024 742.40 Mn
Sep 30, 2024 771.90 Mn
Jun 30, 2024 585.66 Mn
Mar 31, 2024 630.38 Mn
Dec 31, 2023 490.42 Mn
Sep 30, 2023 328.76 Mn
Jun 30, 2023 351.47 Mn
Mar 31, 2023 386.64 Mn
Dec 31, 2022 435.09 Mn
Sep 30, 2022 440.58 Mn
Jun 30, 2022 169.81 Mn
Mar 31, 2022 183.17 Mn
Dec 31, 2021 203.71 Mn
Sep 30, 2021 221.21 Mn
API Access

Viridian Therapeutics, Inc.\DE Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=VRDN&period=max&api_key=YOUR_API_KEY